BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33005796
Number of visits today
1047
Number of downloads
16194211
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Deng L, Yang X, Fan J, Ding Y, Peng Y, Xu D, Huang B, Hu Z. IL-24-Armed Oncolytic Vaccinia Virus Exerts Potent Antitumor Effects via Multiple Pathways in Colorectal Cancer. Oncol Res 2021;28:579-90. [PMID: 32641200 DOI: 10.3727/096504020X15942028641011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Thangavelu S, Ramanthan S, Velmurugan P, Dhandapani R. Virotherapy. Viral Infections and Antiviral Therapies 2023. [DOI: 10.1016/b978-0-323-91814-5.00030-1] [Reference Citation Analysis]
2 Ling Q, Zheng B, Chen X, Ye S, Cheng Q. The employment of vaccinia virus for colorectal cancer treatment: A review of preclinical and clinical studies. Hum Vaccin Immunother 2022;18:2143698. [PMID: 36369829 DOI: 10.1080/21645515.2022.2143698] [Reference Citation Analysis]
3 Zhu Z, McGray AJR, Jiang W, Lu B, Kalinski P, Guo ZS. Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways. Mol Cancer 2022;21:196. [PMID: 36221123 DOI: 10.1186/s12943-022-01664-z] [Reference Citation Analysis]
4 Jia W, Zhang T, Huang H, Feng H, Wang S, Guo Z, Luo Z, Ji X, Cheng X, Zhao R. Colorectal cancer vaccines: The current scenario and future prospects. Front Immunol 2022;13:942235. [DOI: 10.3389/fimmu.2022.942235] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ren Y, Miao J, Wang Y, Fan Z, Kong X, Yang L, Cheng G. Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option. Front Immunol 2022;13:961796. [DOI: 10.3389/fimmu.2022.961796] [Reference Citation Analysis]
6 Luo D, Wang H, Wang Q, Liang W, Liu B, Xue D, Yang Y, Ma B. Senecavirus A as an Oncolytic Virus: Prospects, Challenges and Development Directions. Front Oncol 2022;12:839536. [PMID: 35371972 DOI: 10.3389/fonc.2022.839536] [Reference Citation Analysis]
7 Liu Y, Chen Y, Zhu R, Xu L, Xie HQ, Zhao B. Rutaecarpine Inhibits U87 Glioblastoma Cell Migration by Activating the Aryl Hydrocarbon Receptor Signaling Pathway. Front Mol Neurosci 2021;14:765712. [PMID: 34955744 DOI: 10.3389/fnmol.2021.765712] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345